The combined use of mammography, ultrasonography, and magnetic resonance imaging provides the highest diagnostic performance, reduces false negatives, and is suitable for staging and high genetic risk evaluation.
Background: Breast cancer is one of the most common causes of cancer-related morbidity and mortality among
women worldwide. Early diagnosis is essential for enhancing survival and treatment outcomes. Sonomammography,
which combines ultrasound and mammography, improves lesion detection and characterization, especially...
Mayuri Ojah, Priyanka Bhattacharyya, Bhargav Das· Indian Journal of Public Hea...· 0 citations
Background and Objective: Breast imaging-reporting and data system (BI-RADS) is intended forstandardizing mammography reporting, and class IV A represents low suspicion of malignancy. Theobjective of this study was to assess the diagnostic accuracy of mammography in assessment of breast lesions(BIRADS IVA) taking histo...
R. Irum, Aneeza Qayyum, Fatima Khan· JAIMC: Journal of Allama Iqb...· 0 citations
BACKGROUND
Breast cancer remains the leading cause of cancer-related mortality among women. The high mortality rate is due to late detection, low awareness, inadequate screening programs, and limited access to diagnostic and treatment options.
OBJECTIVES
Aim is to evaluate the diagnostic performance of iBreastExam (i...
Meenakshi Khapre, A. M, Farhanul Huda et al.· Journal of the National Medi...· 0 citations
The results confirm the hypothesis that LLMs, when instructed through Prompt Engineering, can achieve performance comparable to or superior to manual extraction by health professionals, and demonstrate its potential as a complementary verification tool alongside specialists.
L. Farias, Hanna Reckziegel, Daniela Duarte da Silva Bagatini et al.· 0 citations
Objective To evaluate the diagnostic accuracy of combined ultrasound elastography and magnetic resonance imaging in patients with breast cancer. Methods This was a retrospective diagnostic accuracy study. We designated 60 patients diagnosed with breast cancer between August 2021 and November 2023 as the case group, and...
Peng-Hua Zhang, Ya-Ning Gu· Breast Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.